Komunikaty firm · 16.10.2026

Perceptive Discovery Launches Astatine-211 Study Capabilities in the US and UK

Perceptive Discovery has become the first US provider to support Astatine-211 studies, expanding access to specialized radiopharmaceutical development infrastructure through its collaboration with Atley Solutions.